SEC Comment Letter for ProPhase Labs, Inc. (PRPH) (CIK 0000868278) (PRPH) — Aug 18, 2025
ProPhase Labs, Inc. (PRPH) (CIK 0000868278)
Date: Aug. 18, 2025 · CIK: 0000868278 · Accession: 0000000000-25-008686
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-21617
Letter
Re: ProPhase Labs, Inc. Preliminary Proxy Statement on Schedule 14A Filed July 28, 2025 File No. 000-21617 Dear Ted Karkus:
August 18, 2025
Ted Karkus Chief Executive Officer ProPhase Labs, Inc. 626 RXR Plaza, 6th Floor Uniondale, NY 11556
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
cc: Julie Kamps, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 18, 2025 Ted Karkus Chief Executive Officer ProPhase Labs, Inc. 626 RXR Plaza, 6th Floor Uniondale, NY 11556 Re: ProPhase Labs, Inc. Preliminary Proxy Statement on Schedule 14A Filed July 28, 2025 File No. 000-21617 Dear Ted Karkus: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Julie Kamps, Esq. </TEXT> </DOCUMENT>